Matti Höyhtyä

3.9k total citations
50 papers, 3.4k citations indexed

About

Matti Höyhtyä is a scholar working on Cancer Research, Oncology and Molecular Biology. According to data from OpenAlex, Matti Höyhtyä has authored 50 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Cancer Research, 20 papers in Oncology and 16 papers in Molecular Biology. Recurrent topics in Matti Höyhtyä's work include Protease and Inhibitor Mechanisms (28 papers), Peptidase Inhibition and Analysis (18 papers) and Cell Adhesion Molecules Research (13 papers). Matti Höyhtyä is often cited by papers focused on Protease and Inhibitor Mechanisms (28 papers), Peptidase Inhibition and Analysis (18 papers) and Cell Adhesion Molecules Research (13 papers). Matti Höyhtyä collaborates with scholars based in Finland, United States and Sweden. Matti Höyhtyä's co-authors include Karl Tryggvason, Tuula Salo, Taina Turpeenniemi‐Hujanen, Charles Pyke, Lance A. Liotta, T Hurskainen, William G. Stetler‐Stevenson, Helena Autio‐Harmainen, M.G. Byers and Seppo T. Nikkari and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Matti Höyhtyä

50 papers receiving 3.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matti Höyhtyä Finland 32 1.9k 1.3k 1.1k 848 636 50 3.4k
Steingrimur Stefansson United States 27 1.5k 0.8× 559 0.4× 1.4k 1.4× 614 0.7× 838 1.3× 48 3.3k
Erik Maquoi Belgium 35 1.5k 0.8× 1.0k 0.8× 1.3k 1.2× 500 0.6× 373 0.6× 59 3.3k
Khalid Bajou Belgium 25 1.6k 0.9× 627 0.5× 1.4k 1.3× 581 0.7× 704 1.1× 42 3.0k
Jean Michel Foidart Belgium 32 936 0.5× 1.3k 1.0× 1.2k 1.1× 523 0.6× 298 0.5× 70 4.1k
M. C. Rio France 22 1.6k 0.9× 1.5k 1.1× 1.5k 1.4× 594 0.7× 365 0.6× 31 3.6k
Lars H. Engelholm Denmark 31 1.2k 0.6× 1.1k 0.8× 1.3k 1.2× 730 0.9× 330 0.5× 79 3.4k
Gabriella Fibbi Italy 37 1.3k 0.7× 650 0.5× 1.6k 1.5× 385 0.5× 524 0.8× 120 3.2k
James R. Birkhead United States 8 1.7k 0.9× 904 0.7× 3.0k 2.8× 983 1.2× 232 0.4× 8 4.8k
Massimo Resnati Italy 22 1.1k 0.6× 499 0.4× 1.5k 1.5× 837 1.0× 619 1.0× 35 3.4k
Helene Solberg Denmark 18 930 0.5× 733 0.6× 1.0k 1.0× 290 0.3× 474 0.7× 24 2.4k

Countries citing papers authored by Matti Höyhtyä

Since Specialization
Citations

This map shows the geographic impact of Matti Höyhtyä's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matti Höyhtyä with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matti Höyhtyä more than expected).

Fields of papers citing papers by Matti Höyhtyä

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matti Höyhtyä. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matti Höyhtyä. The network helps show where Matti Höyhtyä may publish in the future.

Co-authorship network of co-authors of Matti Höyhtyä

This figure shows the co-authorship network connecting the top 25 collaborators of Matti Höyhtyä. A scholar is included among the top collaborators of Matti Höyhtyä based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matti Höyhtyä. Matti Höyhtyä is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Paus, Elisabeth, et al.. (2011). TD-12 workshop report: characterization of monoclonal antibodies to neuron-specific enolase. Tumor Biology. 32(4). 819–829. 8 indexed citations
2.
Takkinen, Kristiina, et al.. (2010). The testosterone binding mechanism of an antibody derived from a naïve human scFv library. Journal of Molecular Recognition. 24(2). 209–219. 11 indexed citations
3.
Wu, Xingchen, Hanna Kuusisto, Prasun Dastidar, et al.. (2007). Once-weekly 22?g subcutaneous IFN-?-1a in secondary progressive MS: a 3-year follow-up study on brain MRI measurements and serum MMP-9 levels. Acta Neurologica Scandinavica. 116(1). 43–48. 3 indexed citations
4.
Solakivi, Tiina, Olli Jaakkola, Terho Lehtimäki, et al.. (2005). Lipoprotein docosapentaenoic acid is associated with serum matrix metalloproteinase-9 concentration. Lipids in Health and Disease. 4(1). 8–8. 9 indexed citations
5.
Jaakkola, Olli, et al.. (2004). Serum matrix metalloproteinase‐9 is elevated in men with a history of myocardial infarction. Scandinavian Journal of Clinical and Laboratory Investigation. 64(3). 255–262. 26 indexed citations
6.
Höyhtyä, Matti, et al.. (2002). Association of serum MMP-9 with autoantibodies against oxidized LDL. Atherosclerosis. 160(1). 161–165. 13 indexed citations
7.
Sillanaukee, P, et al.. (2002). Matrix metalloproteinase‐9 is elevated in serum of alcohol abusers. European Journal of Clinical Investigation. 32(4). 225–229. 35 indexed citations
8.
Sisto, Tero, et al.. (2002). Serum matrix metalloproteinase-9 concentration in angiographically assessed coronary artery disease. Scandinavian Journal of Clinical and Laboratory Investigation. 62(5). 337–342. 68 indexed citations
9.
Sassi, Mirja-Liisa, Arja Jukkola‐Vuorinen, Riitta Riekki, et al.. (2001). Type I collagen turnover and cross-linking are increased in irradiated skin of breast cancer patients. Radiotherapy and Oncology. 58(3). 317–323. 33 indexed citations
10.
Koskinen, S. O.A., Matti Höyhtyä, Taina Turpeenniemi‐Hujanen, et al.. (2001). Serum concentrations of collagen degrading enzymes and their inhibitors after downhill running. Scandinavian Journal of Medicine and Science in Sports. 11(1). 9–15. 68 indexed citations
11.
Herva, Riitta, et al.. (2000). Matrix Metalloproteinase 2 (MMP-2) Immunoreactive Protein is Associated with Poor Grade and Survival in Brain Neoplasms. Journal of Neuro-Oncology. 46(1). 81–90. 64 indexed citations
12.
Reuter, Alexander, Ralf M. Zwacka, Jan Tuckermann, et al.. (1998). Expression of the Recessive Glomerulosclerosis Gene Mpv17 Regulates MMP-2 Expression in Fibroblasts, the Kidney, and the Inner Ear of Mice. Molecular Biology of the Cell. 9(7). 1675–1682. 23 indexed citations
13.
Johansson, Kjell Arne, et al.. (1997). Expression of tissue inhibitor of metalloproteinases TIMP-2 in human colorectal cancer - a predictor of tumour stage. British Journal of Cancer. 76(6). 805–811. 80 indexed citations
15.
Soini, Ylermi, T Hurskainen, Matti Höyhtyä, A Oikarinen, & Helena Autio‐Harmainen. (1994). 72 KD and 92 KD type IV collagenase, type IV collagen, and laminin mRNAs in breast cancer: a study by in situ hybridization.. Journal of Histochemistry & Cytochemistry. 42(7). 945–951. 90 indexed citations
16.
Visscher, Daniel W., Matti Höyhtyä, Chi‐Ming Liang, et al.. (1994). Enhanced expression of tissue inhibitor of metalloproteinase‐2 (TIMP‐2) in the stroma of breast carcinomas correlates with tumor recurrence. International Journal of Cancer. 59(3). 339–344. 143 indexed citations
17.
Fridman, Rafael, Robert E. Bird, Matti Höyhtyä, et al.. (1993). Expression of human recombinant 72 kDa gelatinase and tissue inhibitor of metalloproteinase-2 (TIMP-2): characterization of complex and free enzyme. Biochemical Journal. 289(2). 411–416. 74 indexed citations
18.
Höyhtyä, Matti, Erkki Hujanen, Taina Turpeenniemi‐Hujanen, et al.. (1990). Modulation of type‐iv collagenase activity and invasive behavior of metastatic human melanoma (A2058) cells in vitro by monoclonal antibodies to type‐iv collagenase. International Journal of Cancer. 46(2). 282–286. 67 indexed citations
19.
Tryggvason, Karl, Matti Höyhtyä, & Tuula Salo. (1987). Proteolytic degradation of extracellular matrix in tumor invasion. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 907(3). 191–217. 432 indexed citations
20.
Höyhtyä, Matti, et al.. (1984). Monoclonal antibodies to human prolyl 4-hydroxylase. European Journal of Biochemistry. 141(3). 477–482. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026